Latest News

Lithium Battery Fire Burns Passenger on Air Canada Flight

A lithium battery fire erupted from a woman’s cellphone onboard an Air Canada plane as it was preparing for takeoff from Toronto’s Pearson International Airport Thursday, March 1. According to CBC News, police confirmed that the lithium battery fire, described by one passenger as a “small campfire-sized flame,” stemmed from an LG cell phone. The incident happened inside the cabin of Air Canada Flight 101 as it was on the tarmac preparing for departure to Vancouver. Paramedics said the woman was taken to a local hospital with first-degree burn injuries on her hands. No other passengers were injured. According to ... Read More

Evamist HRT recalled due to packaging defect

Perrigo is notifying pharmacists that it is recalling one batch of the hormone replacement therapy (HRT) Evamist Transdermal Spray because there may be cracks in the neck of the vial near the crimp that may cause the product to evaporate or leak out, and thus not properly dispense. This defect may cause consumers to miss the therapeutic benefit of the product in relieving of their menopausal symptoms. Perrigo notified the Food and Drug Administration (FDA) of the recall, and asked pharmacists and distributors with affected products to return them to the company. In accordance with FDA guidelines, Perrigo must verify notifications ... Read More

Xarelto makers don’t want patients to amend complaint

A month before a new round of bellwether trials is scheduled to begin in a mass tort program involving the blood thinner Xarelto, drug makers Johnson & Johnson’s Janssen Pharmaceuticals and Bayer have asked a Pennsylvania judge not to allow a substantially amended master complaint because they say it would significantly prejudice them in presenting a logical defense. There are 1,700 Xarelto-related cases in the mass tort program in the Philadelphia County Court of Common Pleas. The new master complaint lays out general allegations regarding bleeding risks on each case. Created in January 2015, the mass tort alleges that Janssen ... Read More

Sagent recalls injectable anti-inflammatory drug

Sagent Pharmaceuticals Inc., announced a nationwide recall of 10 lots of the injectable anti-inflammatory drug methylprednisolone sodium succinate manufactured by Gland Pharma Ltd., and distributed by Sagent Pharmaceuticals because testing has revealed a high amount of specification impurity. This could decrease the effectiveness of the drug in patients. The impurity has not yet been identified and, to date, no reports of adverse events have been reported. Methylprednisolone sodium succinate for injection is an anti-inflammatory glucocorticoid that is used for several conditions including allergic states, dermatologic diseases, endocrine disorders, gastrointestinal diseases, hematologic disorders, neoplastic diseases, nervous system, ophthalmic diseases, renal diseases, ... Read More

OSHA Settles Whistleblower Retaliation Case With Ohio Co

A whistleblower who lost his job after reporting his concerns about unsafe working conditions at an Ohio-based environmental remediation and emergency-response company will receive $21,000 in back wages, the U.S. Occupational Safety and Health Administration (OSHA) said. The agency ordered Environmental Management Specialists Inc. (EMS) of Steubenville, Ohio, to compensate the worker for the lost work and to erase from his employment record his termination and all references to it that could harm his ability to find other employment. The worker, a field technician, claimed that EMS fired him after he filed whistleblower complaints with OSHA alleging EMS violated occupational ... Read More

Hospira recalls opioid injection

Hospira Inc., is recalling three lots of injectable opioid hydromorphone at the hospital/institution level because glass vials from these lots may be empty or cracked, in which case the sterility of the drug compromised. Use or exposure to hydromorphone from cracked glass vials may cause adverse events including cuts to health care professionals, and bloodstream infections, which may potentially lead to bacteremia or sepsis, to patients. Patients with compromised immune systems are at greater for infections. The recall affects three lots of hydromorphone HCl injection, USP CII 10 mg/mL, 1 mL in 2 mL single dose vials with the lot ... Read More

Whistleblower Case Recovers $1.65 Million From Vermont Hospital

A whistleblower complaint filed against a Vermont hospital by one of its former administrators has ended in a $1.65 million settlement. Brattleboro Memorial Hospital agreed to pay the U.S. and the State of Vermont the sum to resolve allegations that it knowingly submitted or caused the submission of false claims to the Medicare and Medicaid programs. Amy Beth Main filed the lawsuit on behalf of the U.S. and Vermont under the whistleblower provisions of the federal and Vermont False Claims Acts. Plaintiff’s counsel told the Brattleboro Reformer that Ms. Main, an administrator in Brattleboro Memorial’s financial services department, “protested internally” ... Read More

Gamer supplement claims to improve reaction speed, cognition

A new dietary supplement is targeting gamers, promising it can “supercharge your memory,” “improve your reaction speed by 6-10 percent” and help you “think faster/smarter.” But the supplement’s claims are raising eyebrows with federal regulators. Frisco, Texas-based Boss Level Labs’ new brain supplement GodMode is sold online and its label says its ingredients are “FDA approved.” But the Food and Drug Administration (FDA) didn’t approve its ingredients. In fact, a reporter with C-Net contacted the agency and learned that it doesn’t approval the ingredients in any dietary supplement. “What I learned is that more than a dozen scientists, health experts ... Read More

FDA warns not to use compounded drugs from Cantrell

The Food and Drug Administration (FDA) is alerting health care professionals and patients not to use drug products produced by Cantrell Drug Company of Little Rock, Arkansas, including opioids and other drugs intended for sterile injection, because there are serious deficiencies with the company’s compounding operations that put the sterility of the products into question. The FDA cautioned in a news release that administration of contaminated or otherwise poor quality drug products can result in “serious and life-threatening injury or death.” “A key aspect of the FDA’s mission to protect public health is creating a regulatory framework that helps ensure ... Read More

FDA warns consumers about fraudulent flu remedies

Reports of flu this season have been as high as what was observed during the peak of the H1N1 2009 pandemic, which has the Food and Drug Administration (FDA) concerned that some manufacturers of medicines, dietary supplements and other products may be trying to lure consumers into buying unproven flu treatments or, even worse, buying counterfeit antivirals online from websites that appear to be legitimate online pharmacies. “This year the flu has been widespread, impacting millions of patients across the country, and leading to a new record number of flu-related hospitalizations,” said FDA Commissioner Scott Gottlieb, M.D. “As the flu ... Read More